AOK Nordost. Die Gesundheitskasse.
Germany · 56 open tenders · 499 documented awards
Current tenders
Conclusion of non-exclusive discount agreements pursuant to §130a (8) SGB V for various active ingredients/combinations with the possibility of conclusion at any time within the scope of the so-called Open House procedure
Deadline 5 Dec ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient(s)/combinations with the possibility of conclusion at any time within the framework of the so-called Open House procedure
Deadline 5 Dec ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient(s)/combinations with the possibility of conclusion at any time within the scope of the so-called Open House procedure
Deadline 5 Dec ·
Contrast Agent Cross-Active Ingredient Open House Procedure for the KV Region Mecklenburg-Vorpommern
Deadline 15 Feb ·
Contrast agent active ingredient-independent open house procedure for the KV Region Mecklenburg-Vorpommern
Deadline 15 Feb ·
Open-House Drug Discount Agreements pursuant to § 130a paragraph 8c SGB V for the KV Region Brandenburg
Deadline 21 Feb ·
Open-House Drug Discount Agreements pursuant to § 130a paragraph 8c SGB V for the KV region Berlin
Deadline 21 Feb ·
Open-House Pharmaceutical Rebate Agreements pursuant to § 130a subsection 8c SGB V for the KV Region Mecklenburg-Vorpommern
Deadline 21 Feb ·
Open-House Pharmacy Rebate Agreements pursuant to § 130a para. 8c SGB V for the KV Region Brandenburg
Deadline 21 Feb ·
Open-House Pharmaceutical Rebate Agreements pursuant to § 130a para. 8c SGB V for the KV region Mecklenburg-Vorpommern
Deadline 21 Feb ·
Open-House Drug Discount Agreements pursuant to § 130a para. 8c SGB V for the KV Region Brandenburg
Deadline 21 Feb ·
Open-House Drug Discount Agreements pursuant to § 130a Paragraph 8c SGB V for the KV Region Berlin
Deadline 21 Feb ·
Open-House Drug Rebate Agreements pursuant to § 130a para. 8c SGB V for the KV Region Brandenburg
Deadline 21 Feb ·
Open-House Pharmaceutical Discount Agreements pursuant to § 130a para. 8c SGB V for the KV Region Mecklenburg-Vorpommern
Deadline 21 Feb ·
Open-House Drug Discount Agreements pursuant to § 130a para. 8c SGB V for the KV Region Berlin
Deadline 21 Feb ·
Open-House Pharmaceutical Discount Agreements pursuant to § 130a para. 8c SGB V for the KV Region Berlin
Deadline 21 Feb ·
Open-House Pharmaceutical Discount Agreements pursuant to § 130a para. 8c SGB V for the KV Region Mecklenburg-Vorpommern
Deadline 21 Feb ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient/combination(s) with the possibility of concluding agreements at any time within the framework of the so-called Open House procedure
Deadline 5 Mar ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient/combinations with the possibility of concluding agreements at any time within the framework of the so-called Open House procedure
Deadline 5 Mar ·
Conclusion of non-exclusive discount agreements pursuant to §130a paragraph 8 SGB V for various active ingredient(s)/combinations with the possibility of conclusion at any time within the framework of the so-called Open House procedure
Deadline 5 Mar ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient(s)/combinations with the possibility of concluding agreements at any time within the framework of the so-called Open House procedure
Deadline 5 Mar ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredients/combinations with possibility of conclusion at any time within the scope of the so-called Open House procedure
Deadline 5 Mar ·
Contrast agent active substance cross-cutting open house procedure for the KV region Berlin
Deadline 15 Apr ·
Contrast Agent Active Ingredient Cross-Cutting Open House Procedure for the KV Region Berlin
Deadline 15 Apr ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient/combinations with the possibility of conclusion at any time within the scope of the so-called Open House procedure
Deadline 5 Jun ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient(s)/combinations with open conclusion possibility within the so-called Open House procedure
Deadline 5 Jun ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient/combination of active ingredients with the possibility of concluding agreements at any time within the scope of the so-called Open House procedure
Deadline 5 Jun ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredients/combinations with the possibility of concluding at any time within the scope of the so-called Open House procedure
Deadline 5 Jun ·
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient(s)/combinations with possibility of conclusion at any time within the scope of the so-called Open House procedure
Deadline 5 Sept ·
Conclusion of non-exclusive discount agreements pursuant to §130a Abs.8 SGB V for various active ingredients/combinations with the possibility of conclusion at any time within the framework of the so-called Open House procedure
Deadline 5 Sept ·
Purchasing rhythm
Awards per year — who knows the rhythm prepares before the notice appears.
201853
201981
202039
202127
202224
202342
202460
202582
202628
Clement What the numbers say about this buyer
- 24% of this buyer's awards went to companies that had already won here before (59 awards since 2018, spread over 45 companies). That is well below the national norm (45%) — this buyer switches suppliers more often than others.n = 59 awards since 2018
- The median procedure drew 2 bids (59 procedures with a bid count); 47% ended with a single bidder. Country: median 3.1 bids.n = 59
- Across 24 procedures with structured selection criteria, this buyer most often required: Staff qualifications (23 of 24), Trade register enrolment (22 of 24), Security of supply required (1 of 24), Professional liability insurance (1 of 24).n = 24
- Not one of the 59 awards with a known winner country has gone to a foreign company so far. National average: 1%.n = 59
- From notice to award takes a median 65 days here (6 procedures). Country: 91 days.n = 6
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 21 | 2013–2016 |
| ratiopharm GmbH | 17 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 15 | 2013–2016 |
| STADAPHARM GmbH · Bad Vilbel | 13 | 2014–2016 |
| TAD Pharma GmbH · Cuxhaven | 12 | 2013–2016 |
| neuraxpharm Arzneimittel GmbH · Langenfeld | 11 | 2014–2016 |
| betapharm Arzneimittel GmbH · Augsburg | 11 | 2014–2016 |
| Heumann Pharma GmbH & Co. Generica KG · Nürnberg | 11 | 2013–2016 |
| Glenmark Arzneimittel GmbH · Gröbenzell | 10 | 2014–2015 |
| Zentiva Pharma GmbH · Frankfurt am Main | 10 | 2014–2016 |
From 18.0M documented awards · regular winners know this buyer's requirements — that is your competition.